Back
Wolman Disease in Bulgarian Patients: Selective Genetic Screening in Two Presumable Endemic Regions
Angelina Mandadzhieva, Daniela Avdzhieva-Tzavella, Tihomir Todorov, Savina Tincheva, Vanya Sinigerska, Mariya Ivanova, Alexey Savov, Vanyo Mitev, Albena Todorova
Am. J. Mol. Biol. Vol.7 No.4, September 14, 2017  DOI: 10.4236/ajmb.2017.74013
       (PDF  462K)     HTML      XML
Modelling the Financial Framework of the Pharmacotherapy Cost of Rare Diseases with Orphan Medicines—Part II
Albena Zlatareva, Konstantin Tachkov, Milena Stoicheva, Svetla Georgieva, Maria Krasteva Bozhkova, Guenka Petrova
Mod. Econ. Vol.5 No.5, May 20, 2014  DOI: 10.4236/me.2014.55047
       (PDF  523K)     HTML     
Financial Analysis of the Access to Pharmacotherapy for Rare Diseases in Bulgaria
Albena Zlatareva, Konstantin Tachkov, Milena Stoicheva, Svetla Georgieva, Georgi Momekov, Guenka Petrova
Mod. Econ. Vol.5 No.5, May 13, 2014  DOI: 10.4236/me.2014.55044
       (PDF  283K)     HTML     
Prospective Study of the Changes in Pharmacotherapy Cost of Adult Kidney Transplant Patients in Bulgaria
Svetla Georgieva, Guenka Petrova, Maria Dimitrova, Lily Peikova, Emil Paskalev, Jean Filipov, Borelli Zlatkov
Mod. Econ. Vol.4 No.12, December 17, 2013  DOI: 10.4236/me.2013.412089
       (PDF  306K)     HTML     
Cross Skin Reactivity to Tyrosine Kinase Inhibitors in a Patient with Chronic Myelogenous Leukemia
V. Broshtilova, M. Balabanova
J. Cancer Ther. Vol.4 No.7, August 16, 2013  DOI: 10.4236/jct.2013.47130
       (PDF  262K)     HTML      XML
 
 
Top